RGLS logo

Regulus Therapeutics (RGLS) Company Overview

Profile

Full Name:

Regulus Therapeutics Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 9, 2012

Indexes:

Not included

Description:

Regulus Therapeutics is a biopharmaceutical company focused on developing innovative therapies using microRNA technology. They aim to treat various diseases, including cancer and kidney disorders, by targeting specific RNA molecules to regulate gene expression and improve patient outcomes.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 29, 2022

Analyst ratings

Recent major analysts updates

Feb 26, 25 HC Wainwright & Co.
Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Oct 30, 24 HC Wainwright & Co.
Buy
Aug 14, 24 Oppenheimer
Outperform
Aug 9, 24 HC Wainwright & Co.
Buy
Jul 16, 24 HC Wainwright & Co.
Buy
Jun 25, 24 HC Wainwright & Co.
Buy
Jun 25, 24 Canaccord Genuity
Buy
May 31, 24 Jones Trading
Buy
May 10, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Regulus Therapeutics?
  • Does Regulus Therapeutics pay dividends?
  • What sector is Regulus Therapeutics in?
  • What industry is Regulus Therapeutics in?
  • What country is Regulus Therapeutics based in?
  • When did Regulus Therapeutics go public?
  • Is Regulus Therapeutics in the S&P 500?
  • Is Regulus Therapeutics in the NASDAQ 100?
  • Is Regulus Therapeutics in the Dow Jones?
  • When was Regulus Therapeutics's last earnings report?
  • When does Regulus Therapeutics report earnings?
  • Should I buy Regulus Therapeutics stock now?

What is the ticker symbol for Regulus Therapeutics?

The ticker symbol for Regulus Therapeutics is NASDAQ:RGLS

Does Regulus Therapeutics pay dividends?

No, Regulus Therapeutics does not pay dividends

What sector is Regulus Therapeutics in?

Regulus Therapeutics is in the Healthcare sector

What industry is Regulus Therapeutics in?

Regulus Therapeutics is in the Biotechnology industry

What country is Regulus Therapeutics based in?

Regulus Therapeutics is headquartered in United States

When did Regulus Therapeutics go public?

Regulus Therapeutics's initial public offering (IPO) was on October 9, 2012

Is Regulus Therapeutics in the S&P 500?

No, Regulus Therapeutics is not included in the S&P 500 index

Is Regulus Therapeutics in the NASDAQ 100?

No, Regulus Therapeutics is not included in the NASDAQ 100 index

Is Regulus Therapeutics in the Dow Jones?

No, Regulus Therapeutics is not included in the Dow Jones index

When was Regulus Therapeutics's last earnings report?

Regulus Therapeutics's most recent earnings report was on Nov 7, 2024

When does Regulus Therapeutics report earnings?

The next expected earnings date for Regulus Therapeutics is Mar 21, 2025

Should I buy Regulus Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions